Histamine type 2-receptor antagonists and cancer immunotherapy

Compr Ther. 1990 Jan;16(1):8-13.

Author

T Smith¹

Affiliation

¹ Division of Hematology/Oncology, Massey Cancer Center, Medical College of Virginia, Richmond 23298-0037.

PMID: 1967999

No abstract available

Publication types

Clinical Trial
Review

MeSH terms

Cimetidine / therapeutic use
Clinical Trials as Topic
Famotidine / therapeutic use
Histamine H2 Antagonists / therapeutic use*
Humans
Immunotherapy*
Neoplasms / immunology
Neoplasms / therapy*
Ranitidine / therapeutic use
Suppressor Factors, Immunologic

Substances

Histamine H2 Antagonists
Suppressor Factors, Immunologic
Famotidine
Cimetidine
Ranitidine